null - FindTrial

N/A - IRIHS-RÉA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-003004-69-FR

Enrollment

172

Registered

2015-06-26

Start date

2015-01-16

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: FUROSEMIDE Product Name: Furosémide Pharmaceutical Form: Solution for infusion INN or Proposed INN: FUROSEMIDE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactDirection recherche , CHU de Nantes

CHU de Nantes

june.fortin@chu-nantes.fr00330253482844

Outcome results